Filter
1520
Filtered Results: 1520
Text search:
drug
approval
Featured
Recommendations
108
New Publications
445
Language
Document type
No document type
910
Studies & Reports
266
Guidelines
188
Manuals
67
Strategic & Response Plan
36
Fact sheets
28
Training Material
15
Situation Updates
4
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
43
Nigeria
39
South Africa
37
Malawi
35
Nepal
32
Ethiopia
32
Sierra Leone
29
Tanzania
29
Western and Central Europe
29
Myanmar / Burma
26
Ukraine
25
Liberia
25
Bangladesh
24
Ghana
23
Zambia
23
Rwanda
19
Latin America and the Carribbean
19
Lesotho
17
Namibia
17
Zimbabwe
14
Africa
13
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Philippines
8
Cambodia
8
Asia
8
Senegal
7
Tajikistan
6
Thailand
6
Syria
6
Russia
6
Benin
5
Mozambique
5
USA
5
Pakistan
5
China
4
Cameroon
4
Albania
4
Peru
4
Venezuela
4
Germany
4
East and Southern Africa
4
South Sudan
4
Indonesia
4
Afghanistan
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Vietnam
3
Georgia
3
Eswatini/ Swaziland
3
Mexico
2
El Salvador
2
Laos
2
Guinea
2
Middle East and North Africa
2
Western Pacific Region
2
Jamaica
2
Brazil
2
Moldova
2
Central African Republic
2
Bhutan
2
Iraq
2
Somalia
2
Colombia
1
Turkey
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Qatar
1
Armenia
1
Haiti
1
Paraguay
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Argentina
1
Lebanon
1
Sri Lanka
1
Sudan
1
Yemen
1
Palestine
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
667
Clinical Guidelines
125
Public Health
53
Women & Child Health
40
Key Resources
40
Pharmacy & Technologies
36
Capacity Building
12
Toolboxes
HIV
180
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
59
Ebola & Marburg
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
16
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Zika
6
Polio
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Am. J. Trop. Med. Hyg., 106 (Suppl 5), 2022, pp. 56–60. Lymphatic filariasis (LF) is a parasitic disease that is a major cause of chronic disability in the developing world. According to the 2021–2030 road map for neglected tropical diseases (NTDs) published by the World Health Organization (WHO...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
